NeuPath Health

NeuPath Health Equity Growth

The Year-over-Year Equity Growth of NeuPath Health (NPTH.V) as of Nov 12, 2026 is -3.67 %. In the previous year, Year-over-Year Equity Growth was -2.95 % — a change of 24.44% (lower).

Equity Growth

-3.67 %

YoY

24.44%

Last updated:

Year-over-Year Equity Growth of NeuPath Health is 2025 -3.67 % . Year-over-Year Equity Growth of NeuPath Health was 2024 -2.95 % . It decreases by 24.44% lower compared to the previous year.

The NeuPath Health Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2020
182.71 CAD
Jan 1, 2021
-6.49 CAD
Jan 1, 2022
-15.66 CAD
Jan 1, 2023
1.24 CAD
Jan 1, 2024
-2.95 CAD
Jan 1, 2025
-3.67 CAD
The NeuPath Health Equity Growth history
YEAREquity GrowthYoY
-3.67 %+24.44%
-2.95 %-337.79%
1.24 %-107.91%
-15.66 %+141.19%
-6.49 %-103.55%
182.71 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NeuPath Health Stock analysis

What does NeuPath Health do? NeuPath Health, Inc. generates revenue through chronic pain management services provided at its clinics in Ontario and Alberta, offering comprehensive assessments and rehabilitation for chronic pain, musculoskeletal/back injuries, sports injuries, and concussions. The company serves employers and disability insurers with workplace health services and independent medical assessments via a national network of healthcare providers. Additionally, NeuPath provides contract research services to pharmaceutical and biotechnology companies. Its healthcare providers include physiatrists, neurologists, anesthesiologists, general practitioners with specialized pain training, medication management physicians, athletic therapists, and nurses. The primary buyers of NeuPath's services are employers and disability insurers seeking workplace health solutions and independent medical evaluations. Pharmaceutical and biotechnology companies contract NeuPath for research services. The company's clinic services target patients with chronic pain conditions, while its research division serves the pharmaceutical industry. NeuPath's network spans Ontario and Alberta, with a focus on specialized medical expertise across multiple disciplines. NeuPath Health, Inc. operates a network of medical clinics delivering chronic pain management and rehabilitation services. Its national provider network supports workplace health and independent medical assessments for employers and disability insurers. The firm's contract research division works with pharmaceutical and biotechnology companies, leveraging its medical expertise in pain management and rehabilitation. The company's service mix combines direct patient care with specialized industry contracts, creating multiple revenue streams from healthcare providers and corporate clients. NeuPath Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeuPath Health stock

Year-over-Year Equity Growth of NeuPath Health is -3.67 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth NeuPath Health since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's NeuPath Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — NeuPath Health

All Key Metrics — NeuPath Health